Main Management ETF Advisors’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$705K	Buy	5,131 +84	+2%	+$11.5K	0.03%	118
2025 Q1	$910K	Buy	5,047 +1,487	+42%	+$268K	0.04%	73
2024 Q4	$558K	Sell	3,560 -320	-8%	-$50.2K	0.03%	131
2024 Q3	$706K	Buy	+3,880	New	+$706K	0.03%	130